IBDEI0Y8 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16899,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,16899,1,5,0)
 ;;=5^Hx of Affective Disorder
 ;;^UTILITY(U,$J,358.3,16899,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,16900,0)
 ;;=V15.89^^92^943^46
 ;;^UTILITY(U,$J,358.3,16900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16900,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,16900,1,5,0)
 ;;=5^Hx of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,16900,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,16901,0)
 ;;=V11.3^^92^943^25
 ;;^UTILITY(U,$J,358.3,16901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16901,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,16901,1,5,0)
 ;;=5^Hx of Alcoholism
 ;;^UTILITY(U,$J,358.3,16901,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,16902,0)
 ;;=V15.07^^92^943^26
 ;;^UTILITY(U,$J,358.3,16902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16902,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,16902,1,5,0)
 ;;=5^Hx of Allergy to Latex
 ;;^UTILITY(U,$J,358.3,16902,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,16903,0)
 ;;=V13.4^^92^943^27
 ;;^UTILITY(U,$J,358.3,16903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16903,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,16903,1,5,0)
 ;;=5^Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,16903,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,16904,0)
 ;;=V12.72^^92^943^31
 ;;^UTILITY(U,$J,358.3,16904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16904,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,16904,1,5,0)
 ;;=5^Hx of Colon Polyps
 ;;^UTILITY(U,$J,358.3,16904,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,16905,0)
 ;;=V12.59^^92^943^30
 ;;^UTILITY(U,$J,358.3,16905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16905,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,16905,1,5,0)
 ;;=5^Hx of CHF
 ;;^UTILITY(U,$J,358.3,16905,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,16906,0)
 ;;=V45.81^^92^943^29
 ;;^UTILITY(U,$J,358.3,16906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16906,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,16906,1,5,0)
 ;;=5^Hx of CABG
 ;;^UTILITY(U,$J,358.3,16906,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,16907,0)
 ;;=V15.84^^92^943^28
 ;;^UTILITY(U,$J,358.3,16907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16907,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,16907,1,5,0)
 ;;=5^Hx of Asbestos Exposure
 ;;^UTILITY(U,$J,358.3,16907,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,16908,0)
 ;;=V15.85^^92^943^47
 ;;^UTILITY(U,$J,358.3,16908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16908,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,16908,1,5,0)
 ;;=5^Hx of Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,16908,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,16909,0)
 ;;=V10.72^^92^943^34
 ;;^UTILITY(U,$J,358.3,16909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16909,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,16909,1,5,0)
 ;;=5^Hx of Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,16909,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,16910,0)
 ;;=V15.3^^92^943^35
 ;;^UTILITY(U,$J,358.3,16910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16910,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,16910,1,5,0)
 ;;=5^Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,16910,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,16911,0)
 ;;=V10.61^^92^943^37
 ;;^UTILITY(U,$J,358.3,16911,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16911,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,16911,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,16911,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,16912,0)
 ;;=V12.03^^92^943^39
 ;;^UTILITY(U,$J,358.3,16912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16912,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,16912,1,5,0)
 ;;=5^Hx of Malaria
